Welcome to our dedicated page for Accolade news (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade stock.
Accolade, Inc. (ACCD) delivers technology-powered healthcare solutions that combine virtual care with expert clinical navigation. This news hub provides investors and industry professionals with essential updates on the company’s strategic initiatives and market position.
Track official press releases, earnings announcements, and operational developments through our curated collection. Find timely information on healthcare partnerships, service expansions, and technology innovations that shape Accolade’s role in personalized care solutions.
Our repository includes updates across key business areas: financial results, leadership changes, clinical program enhancements, and regulatory milestones. Each entry is sourced directly from company communications to ensure accuracy and compliance.
Bookmark this page for streamlined access to ACCD’s evolving story in healthcare technology. Monitor how the company’s unique blend of digital tools and clinical expertise continues to redefine employer-sponsored and individual healthcare navigation.
Accolade (Nasdaq: ACCD) has released findings from a report showing how its Personalized Healthcare services enhance employee retention, recruitment, and satisfaction. The research indicates that 93% of Accolade members find their healthcare experience easier, while 92% report improved benefits. The study highlights the importance of mental health and virtual healthcare in the competitive talent market, with 61% of employers looking to expand these services. Key findings show that Accolade members value their health benefits more than non-members, indicating a positive perception of their employer's offerings.
Accolade, Inc. (NASDAQ: ACCD) will participate in the 2022 SVB Leerink Global Healthcare Conference, featuring a fireside chat presentation scheduled for February 18, 2022, at 2:20 p.m. E.T. This event highlights Accolade's commitment to transforming healthcare through personalized, data-driven solutions that enhance member experience.
Accolade serves over 600 employers and millions of members, providing virtual primary care, mental health support, and expert medical opinions, achieving consumer satisfaction ratings above 90%. For more details, visit accolade.com.
Accolade, Inc. (NASDAQ: ACCD) will participate in the 24th Annual Needham Growth Conference, presenting on January 14, 2022, at 12:30 p.m. E.T. The event will be accessible via webcast at ir.accolade.com. Accolade provides personalized healthcare solutions, including virtual primary care and mental health support, serving over 600 employers and millions of members. The company emphasizes a data-driven and value-based approach to healthcare, achieving consumer satisfaction ratings above 90%. For further details, visit accolade.com.
Accolade, Inc. (NASDAQ: ACCD) reported fiscal Q3 2022 revenue of $83.5 million, marking a significant 117% increase from Q3 2021. The company aims for 25% revenue growth in fiscal 2023 while reducing Adjusted EBITDA loss. CEO Rajeev Singh highlighted the transformation into a personalized healthcare provider, growing from 100 customers and 2 million members to over 600 customers and 10 million members in just one year. Accolade successfully launched the Accolade Care and Accolade One services on January 1, 2022, further enhancing their healthcare offerings.
Accolade, Inc. (NASDAQ: ACCD) will release its fiscal Q3 2022 financial results on January 10, 2022, after market close. A conference call will follow at 4:30 p.m. E.T. to discuss these results. The call can be accessed by dialing 1-833-519-1281 for U.S. participants or 1-914-800-3853 for international participants, using conference ID # 6077524. A live audio webcast will also be available on the company's investor relations website. The replay of the call will be accessible for approximately 90 days after the event.
Accolade, Inc. (NASDAQ: ACCD) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference, accessible for registered attendees until December 2, 2021. The company supports over 400 employers and millions of members, focusing on personalized, data-driven healthcare experiences. Accolade combines virtual primary care, mental health support, and expert medical opinions through advanced technology, achieving consumer satisfaction ratings above 90%. For more details, visit accolade.com.
Accolade (Nasdaq: ACCD) has announced an expansion of its executive leadership team, welcoming Carolina Lobo as chief marketing officer and Eve Stacey as chief customer officer. This strategic move aims to enhance the company’s Personalized Healthcare offerings, fostering better healthcare experiences for over 400 enterprise customers and nine million members. Lobo will lead brand strategy and engagement, while Stacey will focus on customer success operations. Both leaders bring extensive experience from notable companies, positioning Accolade to strengthen its mission in delivering exceptional healthcare solutions.
Accolade, Inc. (NASDAQ: ACCD) will participate in the Credit Suisse 30th Annual Healthcare Conference with a fireside chat on November 11, 2021, at 12:10 p.m. E.T. The session will be accessible through a webcast on their investor relations website, ir.accolade.com. Accolade is a healthcare provider that offers personalized care solutions to over 400 employers and millions of members, focusing on a value-based approach to improve healthcare outcomes and maintain high consumer satisfaction ratings above 90%.
Accolade (Nasdaq: ACCD) announced a partnership with WellRight, a leader in corporate wellness programs, to enhance its partner ecosystem. This collaboration aims to address employee health benefits, retention, and engagement, aligning with the current demands of employers. WellRight's platform incorporates data from various sources to create personalized wellness plans. The partnership aims to deliver improved health outcomes through a comprehensive approach to employee well-being, emphasizing the importance of personalized healthcare solutions.
FAQ
What is the current stock price of Accolade (ACCD)?
What is the market cap of Accolade (ACCD)?
